Issue Information

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2025)

Identification of three unexpected new psychoactive substances at an Australian drug checking service
di: Jess L. Algar, et al.
Pubblicazione: (2024)

Automated enzymatic hydrolysis of urine samples for improved systematic toxicological analysis of drug‐facilitated sexual assault cases
di: Kathrine Skov, et al.
Pubblicazione: (2024)

Bayesian Individual Limits for IGF‐1 Monitoring in Equine Plasma: Implementation in the Equine Biological Passport
di: Agnès Barnabé, et al.
Pubblicazione: (2024)

Comparison of analytical approaches for the detection of oral testosterone undecanoate administration in men
di: Tobias Langer, et al.
Pubblicazione: (2024)

Demonstration of an End‐To‐End Workflow Using Atmospheric Solids Analysis Probe–Mass Spectrometry (ASAP‐MS) With Real‐Time Sample Recognition Software for the Identification of Falsified and Substandard Pharmaceutical Tablets
di: Fiona Smillie, et al.
Pubblicazione: (2024)

Development and validation of general plasma screening method for performance enhancing drugs in racehorses utilizing liquid chromatography–high‐resolution mass spectrometry (LC–HRMS)
di: Izabela Lomnicka, et al.
Pubblicazione: (2024)

Metabolic Characterization of Vamorolone in Human Liver Microsomes: Implications for Anti‐Doping
di: Zhongquan Li, et al.
Pubblicazione: (2024)

Quantitative analysis of nonsteroidal anti‐inflammatory drugs in dried blood spot from mountain ultra‐trail runners. Contribution of pharmacokinetic models for the interpretation of the results
di: Mohammad Shafiq Mashal, et al.
Pubblicazione: (2024)

Analytical and behavioral characterization of 1‐hexanoyl‐LSD (1H‐LSD)
di: Simon D. Brandt, et al.
Pubblicazione: (2024)

An LC‐MS/MS method for the determination of drugs of abuse included THC‐COOH, EtG, and NPS, using a single hair extraction sample
di: Valentina Longo, et al.
Pubblicazione: (2024)

Analytical advances in horseracing medication and doping control from 2018 to 2023
di: Bob Gray, et al.
Pubblicazione: (2024)

Detection of Δ9‐tetrahydrocannabinol (THC) in oral fluid using two point‐of‐collection testing devices following oral administration of a THC and cannabidiol containing oil
di: Anastasia Suraev, et al.
Pubblicazione: (2024)

Metabolite markers for three synthetic tryptamines N‐ethyl‐N‐propyltryptamine, 4‐hydroxy‐N‐ethyl‐N‐propyltryptamine, and 5‐methoxy‐N‐ethyl‐N‐propyltryptamine
di: Marianne Skov‐Skov Bergh, et al.
Pubblicazione: (2024)

Ambient ionisation mass spectrometry for drug and toxin analysis: A review of the recent literature
di: Alisha Henderson, et al.
Pubblicazione: (2024)

Detection of Oral Testosterone Undecanoate Administration in UGT2B17 del/del and del/ins Individuals. Part II: Urinary Endogenous Steroid Sulfate Markers
di: Sergi Coll, et al.
Pubblicazione: (2024)

Comparison of Microcapillary Blood Sampling Devices for Use in Anti‐Doping
di: Laura Lewis, et al.
Pubblicazione: (2024)

Estimating human pharmacokinetic parameters for electronic nicotine delivery system products from chemical analyses of their aerosols
di: Saul Shiffman, et al.
Pubblicazione: (2024)